BlackRock Institutional Trust Company, N.A. - CARBYLAN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CARBYLAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$2,000
-33.3%
5,0750.0%0.00%
Q2 2016$3,000
-94.3%
5,075
-93.8%
0.00%
Q1 2016$53,000
-82.3%
81,740
-1.4%
0.00%
Q4 2015$300,000
+2.7%
82,935
+1.6%
0.00%
Q3 2015$292,000
-46.8%
81,656
+6.4%
0.00%
Q2 2015$549,00076,7180.00%
Other shareholders
CARBYLAN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,178,941$8,429,0000.45%
SPHERA FUNDS MANAGEMENT LTD. 400,000$2,860,0000.28%
PURA VIDA INVESTMENTS, LLC 40,000$276,0000.14%
Omega Advisors Inc. 100,000$715,0000.01%
PUTNAM INVESTMENTS LLC 634,780$4,539,0000.01%
Pentwater Capital Management LP 225,000$1,609,0000.01%
Alyeska Investment Group, L.P. 199,736$1,428,0000.01%
PANAGORA ASSET MANAGEMENT INC 207,158$1,481,0000.01%
FRANKLIN RESOURCES INC 1,524,100$10,897,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 2,803,300$20,044,0000.00%
View complete list of CARBYLAN THERAPEUTICS INC shareholders